Literature DB >> 17188799

Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography.

Tuomas O Kiviniemi1, Jyri O Toikka, Juha W Koskenvuo, Antti Saraste, Markku Saraste, Jussi P Pärkkä, Olli T Raitakari, Jaakko J Hartiala.   

Abstract

Transthoracic Doppler echocardiography (TTE) has been introduced as a noninvasive tool to measure coronary flow velocity reserve (CFVR). Velocity measurement, however, fails to take into account epicardial coronary artery vasodilation during hyperemia and this may cause underestimation of CFVR measurements. Therefore, we sought to determine whether the vasodilation of epicardial coronary artery can be measured during cold pressor test (CPT) and adenosine infusion simultaneously with the flow velocity measurement using TTE. We studied 41 healthy nonsmoking men with a linear high-frequency 8.0-MHz transducer. The CPT and adenosine infusion dilated the diameter of the distal left anterior descending coronary artery (LAD) from 1.4 +/- 0.4 mm to 1.5 +/- 0.4 mm (14 +/- 13%, p < 0.01) and from 1.4 +/- 0.4 mm to 1.8 +/- 0.5 mm (31 +/- 19%, p < 0.01), respectively. The CPT increased flow velocity and calculated coronary blood flow rate (velocity time integral x cross-sectional area) from 0.23 +/- 0.05 m/s to 0.36 +/- 0.13 m/s (31 +/- 34%, p < 0.01) and from 8.1 +/- 4.2 mL/min to 11.4 +/- 6.0 mL/min (47 +/- 51%, p < 0.01). CFVR and calculated coronary blood flow rate reserve were 3.9 +/- 1.0 and 6.0 +/- 1.9, respectively. In Bland-Altman analysis, velocity measurements underestimated the vasodilation response of the CPT and adenosine compared with the measurements where epicardial diameter dilation was taken into account. Intra- and interobserver variability of diameter measurements was low (coefficient of variation [CV] 2.6 to 6.5%). Day-to-day, within-day and intersonographer variabilities were of similar magnitude (CV 4.6 to 8.2%), suggesting good reproducibility. This study demonstrates that TTE can be used to assess changes in both epicardial coronary artery diameter and flow velocity simultaneously in the distal LAD artery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17188799     DOI: 10.1016/j.ultrasmedbio.2006.08.012

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  13 in total

1.  Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.

Authors:  Pasi Karjalainen; Tuomas O Kiviniemi; Tuomas Lehtinen; Wail Nammas; Antti Ylitalo; Antti Saraste; Jussi Mikkelsson; Mikko Pietila; Fausto Biancari; Juhani K E Airaksinen
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-31       Impact factor: 2.357

2.  Impaired coronary flow reserve in obstructive sleep apnea and its improvement after continuous positive airway pressure therapy: a transthoracic Doppler echocardiographic study.

Authors:  Kikuko Obase; Hiroyuki Okura; Keiji Mouri; Tomoko Maehama; Akihiro Hayashida; Nozomi Watanabe; Yoji Neishi; Takahiro Kawamoto; Mikio Oka; Kiyoshi Yoshida
Journal:  J Echocardiogr       Date:  2010-12-08

3.  Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease.

Authors:  Caterina Marciano; Maurizio Galderisi; Paola Gargiulo; Wanda Acampa; Carmen D'Amore; Roberta Esposito; Enza Capasso; Gianluigi Savarese; Laura Casaretti; Francesco Lo Iudice; Giovanni Esposito; Giuseppe Rengo; Dario Leosco; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-12       Impact factor: 9.236

4.  Coronary Exercise Hyperemia Is Impaired in Patients with Peripheral Arterial Disease.

Authors:  Amanda J Ross; Zhaohui Gao; Jonathan Carter Luck; Cheryl A Blaha; Aimee E Cauffman; Faisal Aziz; John F Radtka; David N Proctor; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller
Journal:  Ann Vasc Surg       Date:  2016-08-27       Impact factor: 1.466

5.  Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.

Authors:  Stephan R Maman; Alvaro F Vargas; Tariq Ali Ahmad; Amanda J Miller; Zhaohui Gao; Urs A Leuenberger; David N Proctor; Matthew D Muller
Journal:  J Appl Physiol (1985)       Date:  2017-06-01

6.  Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Authors:  Tuomas O Kiviniemi; Gennady G Yegutkin; Jyri O Toikka; Subhadeep Paul; Tero Aittokallio; Tuula Janatuinen; Juhani Knuuti; Tapani Rönnemaa; Juha W Koskenvuo; Jaakko J Hartiala; Sirpa Jalkanen; Olli T Raitakari
Journal:  Front Physiol       Date:  2012-08-23       Impact factor: 4.566

7.  Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis.

Authors:  Markus Malmberg; Tommi Vähäsilta; Antti Saraste; Juha W Koskenvuo; Jussi P Pärkkä; Kari Leino; Timo Laitio; Christoffer Stark; Aira Heikkilä; Pekka Saukko; Timo Savunen
Journal:  Front Physiol       Date:  2012-02-14       Impact factor: 4.566

8.  Feasibility and diagnostic power of transthoracic coronary Doppler for coronary flow velocity reserve in patients referred for myocardial perfusion imaging.

Authors:  Eva Maret; Jan Engvall; Eva Nylander; Jan Ohlsson
Journal:  Cardiovasc Ultrasound       Date:  2008-03-29       Impact factor: 2.062

9.  Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men.

Authors:  Tuomas O Kiviniemi; Antti Saraste; Jyri O Toikka; Markku Saraste; Olli T Raitakari; Jussi P Pärkkä; Terho Lehtimäki; Jaakko J Hartiala; Jorma Viikari; Juha W Koskenvuo
Journal:  Cardiovasc Ultrasound       Date:  2008-06-03       Impact factor: 2.062

10.  Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease.

Authors:  Patricia K Nguyen; Craig Meyer; Jan Engvall; Phillip Yang; Michael V McConnell
Journal:  J Cardiovasc Magn Reson       Date:  2008-05-30       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.